Cargando…
Outcomes of transcatheter aortic valve replacement in patients with mitral valve regurgitation
INTRODUCTION: Transcatheter aortic valve replacement (TAVR) is currently considered a class I indication for patients with severe symptomatic aortic stenosis and high/prohibitive surgical risk. AIM: We describe the effect of concomitant mitral valve regurgitation (MR) on post-procedural TAVR outcome...
Autores principales: | Abdullah, Obai, Omran, Jad, Al-Dadah, Ashraf, Enezate, Tariq |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727220/ https://www.ncbi.nlm.nih.gov/pubmed/31497051 http://dx.doi.org/10.5114/aic.2019.86011 |
Ejemplares similares
-
Outcomes of concomitant percutaneous coronary interventions and transcatheter aortic valve replacement
por: Ghrair, Fadi, et al.
Publicado: (2020) -
Transcatheter Aortic Valve Replacement and Concomitant Mitral Regurgitation
por: Stähli, Barbara E., et al.
Publicado: (2018) -
Mitral regurgitation after transcatheter aortic valve replacement
por: Nappi, Francesco, et al.
Publicado: (2020) -
Mitral and aortic regurgitation following transcatheter aortic valve replacement
por: Szymański, Piotr, et al.
Publicado: (2016) -
Atherectomy-assisted versus percutaneous angioplasty interventions for treatment of symptomatic infra-inguinal peripheral arterial disease
por: Abdullah, Obai, et al.
Publicado: (2019)